Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Pain Therapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Pain Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Pain Therapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Pain Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Pain Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Pain Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Pain Therapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Pain Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Pain Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Pain Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Pain Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pain Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Pain Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Pain Therapeutics, Inc. Snapshot 5 Pain Therapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Pain Therapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Pain Therapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pain Therapeutics, Inc. - Pipeline Products Glance 10 Pain Therapeutics, Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 Pain Therapeutics, Inc. - Early Stage Pipeline Products 11 IND/CTA Filed Products/Combination Treatment Modalities 11 Preclinical Products/Combination Treatment Modalities 12 Pain Therapeutics, Inc. - Drug Profiles 13 hydrocodone bitartrate 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 hydromorphone 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 PTI-202 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 PTI-721 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 oxymorphone 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 PTI-125 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 PTI-609 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Pain Therapeutics, Inc. - Pipeline Analysis 20 Pain Therapeutics, Inc. - Pipeline Products by Target 20 Pain Therapeutics, Inc. - Pipeline Products by Route of Administration 21 Pain Therapeutics, Inc. - Pipeline Products by Molecule Type 22 Pain Therapeutics, Inc. - Pipeline Products by Mechanism of Action 23 Pain Therapeutics, Inc. - Recent Pipeline Updates 24 Pain Therapeutics, Inc. - Dormant Projects 25 Pain Therapeutics, Inc. - Discontinued Pipeline Products 26 Discontinued Pipeline Product Profiles 26 naltrexone 26 Pain Therapeutics, Inc. - Company Statement 27 Pain Therapeutics, Inc. - Locations And Subsidiaries 28 Head Office 28 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Pain Therapeutics, Inc., Key Information 5 Pain Therapeutics, Inc., Key Facts 5 Pain Therapeutics, Inc. - Pipeline by Indication, 2014 7 Pain Therapeutics, Inc. - Pipeline by Stage of Development, 2014 8 Pain Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 9 Pain Therapeutics, Inc. - Phase I, 2014 10 Pain Therapeutics, Inc. - IND/CTA Filed, 2014 11 Pain Therapeutics, Inc. - Preclinical, 2014 12 Pain Therapeutics, Inc. - Pipeline by Target, 2014 20 Pain Therapeutics, Inc. - Pipeline by Route of Administration, 2014 21 Pain Therapeutics, Inc. - Pipeline by Molecule Type, 2014 22 Pain Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 23 Pain Therapeutics, Inc. - Recent Pipeline Updates, 2014 24 Pain Therapeutics, Inc. - Dormant Developmental Projects,2014 25 Pain Therapeutics, Inc. - Discontinued Pipeline Products, 2014 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.